Colin Funk, PhD

Scientific Lead


Novateur Advisor Since



Scientific Advisor


Synthesis & Biosynthesis, COVID-19, Immunology, Therapeutics, Vaccines

“We source the facts and deal with the "hard-core" science, leaving sensationalized hype behind.”

Colin Funk, PhD
Scientific Lead

Dr. Colin Funk is a biomedical research scientist, medical writer, and educator with an extensive background in establishing, developing, and leading university-industry research partnerships. His research areas include targeted therapeutics for liver disorders, stem cells and gene editing, inflammatory disease, as well as cannabinoid biosynthesis and endocannabinoids. Dr. Funk is skilled in communication, with successful grant writing that has led to collaborative team projects and influential international publications and presentations.

Currently, Dr. Funk is working for Novateur Ventures on the landscape of cannabinoid biosynthesis. He holds a PhD in Experimental Medicine from McGill University, and he was a postdoctoral researcher in Physiological Chemistry at the Karolinska Institutet in Sweden.

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!